See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $44.2B | 2.6x | 8.9x | |
| $3.4B | 18.9x | 51.4x | |
| $3.4B | 6.7x | 19.6x | |
| $3.1B | 36.7x | -27.0x | |
| $2.4B | 9.7x | -11.8x | |
| $2.4B | 2.9x | 14.2x | |
| $2.1B | 0.8x | 6.0x | |
| $2.0B | 71.4x | -54.8x | |
| $2.0B | 7.1x | 15.0x | |
| $1.8B | n/a | n/a | |
| $1.5B | 6.5x | 27.1x | |
| $1.3B | 5.4x | 15.7x | |
| $1.2B | 5.9x | 27.7x | |
| $1.1B | n/a | n/a | |
| $732M | 3.3x | 43.0x | |
| $714M | 6.2x | n/a | |
| $702M | 8.2x | 23.2x | |
| $685M | 2.5x | 6.1x | |
| $596M | 5.8x | n/a | |
| $535M | 4.1x | -11.0x | |
| $529M | 31.4x | n/a | |
| $518M | 17.0x | -6.4x | |
| $495M | n/a | -4.0x | |
| $388M | 185.3x | -43.1x | |
| $373M | n/a | -16.2x | |
| $329M | 34.9x | n/a | |
| $217M | 0.8x | 7.3x | |
| $215M | 2.0x | 854.6x | |
| $148M | 16.4x | n/a | |
| $144M | n/a | n/a | |
| $130M | 5.3x | -5.5x | |
| $119M | n/a | -4.4x | |
| $112M | 1.8x | n/a | |
| $110M | 3.6x | -1.0x | |
| $81.1M | 7.6x | n/a | |
| $66.6M | 6.0x | n/a | |
| $41.5M | n/a | -0.4x | |
| $16.7M | 50.8x | n/a | |
| -$148M | -18.7x | 1.0x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules